Safety and Effectiveness of Lung Cancer Screening Using Low-Dose Computed Tomography Scan in High-Risk Individuals: A comprehensive review
,
Abstract
Introduction and Aim: Lung cancer is recognized as one of the most prevalent cancers and the most important cause of cancer mortality worldwide. Given the incidence and mortality of this disease, implementing preventive interventions is necessary. In this regard, the present study has investigated the effectiveness of one of the most important interventions of lung cancer screening (using low-dose computed tomography (CT) scan (LDCT)) in high-risk individuals.
Method: The present study is an applied study performed as a comprehensive review. To assess safety, studies on the technical specifications of CT scans and issues related to the safety of applying this device for lung cancer screening were searched and surveyed using keywords in medical databases such as PubMed, Google Scholar, etc. To evaluate the clinical effectiveness, a comprehensive review of all studies regarding health technology assessment, systematic review and meta-analysis studies, and screening guidelines around the world was performed in this regard.
Results: After searching and reviewing the safety issue, 1982 articles were extracted and finally the results of 15 studies were used. The diagnosis of harmless tumors, false positives and performing invasive complementary interventions for them, and the possible negative effects of radiation exposure are safety discussable issues. To measure clinical effectiveness, a total of 17827 studies were found through the surveyed medical databases, and finally 16 studies entered into the final phase of analysis. Based on the synthesis of studies, the effectiveness of lung cancer screening intervention using LDCT has been found to reduce lung cancer mortality by 15% to 20% and mortality from other causes by 0% to 6%. Also, as a result of this screening, the incidence of lung cancer and its diagnosis in the early stages of the disease increase and the incidence of this disease in its upper stages decreases significantly. The findings of the clinical effectiveness survey show that performing this intervention does not create any psychological consequences in individuals’ quality of life.
Conclusion: Lung cancer screening using LDCT in older people with a high smoking history is safer than not performing the intervention, and does not threat the health of individuals undergoing screening. The disadvantages of this screening are negligible compared to its advantages. Compared to non-intervention, this screening is more clinically effective and will lead to a statistically significant reduction in lung cancer mortality and the increase of timely diagnosis of this disease.
2. Hoggart C, Brennan P, Tjonneland A, Vogel U, Overvad K, Ostergaard JN, et al. A risk model for lung cancer incidence. Cancer Prev Res (Phila). 2012;5(6):834-46.
3. Choi CM, Kim HC, Jung CY, Cho DG, Jeon JH, Lee JE, et al. Report of the Korean Association of Lung Cancer Registry (KALC-R), 2014. Cancer Res Treat. 2019;51(4):1400.
4. Jang TW, Oak CH, Chun BK, Jung MH. Detection of pre-invasive endobronchial tumors with D-light/autofluorescence system. J Korean Med Sci. 2006;21(2):242.
5. khezrollah B, Mehdi K. [Staging study and the number of surgeries in patients with lung cancer referred to Imam Reza and Ghaem hospitals of Mashhad University of Medical Sciences].
6. National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365(5):395-409.
7. Saba V. Estimating the Cost Effectiveness of Lung Cancer Screening with Low-dose Computed Tomography Considering Early Detection Rate in Iran. Paramed Sci Military Health. 2016;11(1):1-7.
8. Van Sint Jan S, Sobzack S, Dugailly PM, Feipel V, Lefevre P, Lufimpadio JL, et al. Low-dose computed tomography: a solution for in vivo medical imaging and accurate patient-specific 3D bone modeling? Clin Biomech (Bristol, Avon). 2006;21(9):992-8.
9. Henschke CI, Yankelevitz DF, Yip R, Reeves AP, Farooqi A, Xu D, etal. Lung cancers diagnosed at annual CT screening: volume doubling times. Radiology. 2012;263(2):578-83.
10. Bach PB, Mirkin JN, Oliver TK, Azzoli CG, Berry DA, Brawley OW, et al. Benefits and harms of CT screening for lung cancer: a systematic review. JAMA. 2012;307(22):2418-29.
11. Humphrey LL, Deffebach M, Pappas M, Baumann C, Artis K, Mitchell JP, et al. Screening for lung cancer with low-dose computed tomography: a systematic review to update the US Preventive services task force recommendation. Ann Intern Med. 2013;159(6):411-20.
12. Aberle D, Berg C, Black W, Church T, Fagerstrom R. The National Lung Screening Trial: Overview and study design. Radiology. 2011;258(1):243-53.
13. van Klaveren RJ, Oudkerk M, Prokop M, Scholten ET, Nackaerts K, Vernhout R, et al. Management of lung nodules detected by volume CT scanning. N Engl J Med. 2009;361(23):2221-9.
14. Gopal M, Abdullah SE, Grady JJ, Goodwin JS. Screening for lung cancer with low-dose computed tomography: a systematic review and meta-analysis of the baseline findings of randomized controlled trials. J Thorac Oncol. 2010;5(8):1233-9.
15. Brenner DJ. Radiation risks potentially associated with lowdose CT screening of adult smokers for lung cancer. Radiology. 2004;231(2):440-5.
16. Snowsill T, Yang H, Griffin E, Long L, Varley-Campbell J, Coelho H, et al. Low-dose computed tomography for lung cancer screening in high-risk populations: a systematic review and economic evaluation. Health Technol Assess. 2018;22(69):1-276.
17. Zhou Q, Fan Y, Wang Y, Qiao Y, Wang G, Huang Y, et al. [China National Lung Cancer Screening Guideline with Low-dose Computed Tomography (2018 version)]. Zhongguo Fei Ai Za Zhi. 2018;21(2):67-75.
18. Zhou QH, Fan YG, Bu H, Wang Y, Wu N, Huang YC, et al. China national lung cancer screening guideline with low-dose computed tomography (2015 version). Thorac Cancer. 2015;6(6):812-8.
19. Ellery B, Mundy L, Hiller J. Horizon Scanning Technology, Prioritising Summary Update, Screening for lung cancer utilising computed tomography (CT). Commonwealth of Australia: Australian Goverment; 2010.
20. Black C, Bagust A, Boland A, Walker S, McLeod C, De Verteuil R, et al. The clinical effectiveness and cost-effectiveness of computed tomography screening for lung cancer: systematic reviews. Health Technology Assessment. 2006;10(3).
21. Field JK, Vulkan D, Davies MPA, Duffy SW, Gabe R. Liverpool Lung Project lung cancer risk stratification model: calibration and prospective validation. Thorax. 2021;76(2):161-8.
22. Roberts H, Walker-Dilks C, Sivjee K, Ung Y, Yasufuku K, Hey A, et al. Screening high-risk populations for lung cancer: guideline recommendations. J Thorac Oncol. 2013;8(10):1232-7.
23. Canadian Task Force on Preventive Health C. Recommendations on screening for lung cancer. CMAJ. 2016;188(6):425-32.
24. Huang K-L, Wang S-Y, Lu W-C, Chang Y-H, Su J, Lu Y-T. Effects of low-dose computed tomography on lung cancer screening: a systematic review, meta-analysis, and trial sequential analysis. BMC Pulm Med. 2019;19(1):1-11.
25. Manser R, Lethaby A, Irving LB, Stone C, Byrnes G, Abramson MJ, et al. Screening for lung cancer. Cochrane Database Syst Rev. 2013(6):CD001991.
26. Mazzone PJ, Silvestri GA, Patel S, Kanne JP, Kinsinger LS, Wiener RS, et al. Screening for Lung Cancer: CHEST Guideline and Expert Panel Report. Chest. 2018;153(4):954-85.
27. Slatore CG, Sullivan DR, Pappas M, Humphrey LL. Patient-centered outcomes among lung cancer screening recipients with computed tomography: a systematic review. J Thorac Oncol. 2014;9(7):927-34.
28. Li ZY, Luo L, Hu YH, Chen H, Den YK, Tang L, et al. Lung cancer screening: a systematic review of clinical practice guidelines. Int J Clin Pract. 2016;70(1):20-30.
29. Sadate A, Occean BV, Beregi J-P, Hamard A, Addala T, de Forges H, et al. Systematic review and meta-analysis on the impact of lung cancer screening by low-dose computed tomography. Eur J Cancer. 2020;134:107-14.
30. Church T, Black W, Aberle D, Berg C, Clingan K. Results of initial low-dose computed tomographic screening for lung cancer. N Engl J Med. 2013;368(21):1980-91.
| Files | ||
| Issue | Vol 5, No 2 (2021) | |
| Section | Articles | |
| DOI | https://doi.org/10.18502/htaa.v5i2.8008 | |
| Keywords | ||
| Lung cancer screening Health technology assessment Low-dose CT LDCT scan Smoking Safety Clinical Effectiveness | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
